Porvenir · Marketing for Pharmaceutical & Biotech Companies
Can't Prove Marketing ROI
for
Pharmaceutical & Biotech Companies.
Leadership keeps asking what the marketing budget is actually producing, and you don't have a clean answer.
Fixed for pharmaceutical & biotech companies. Pharmaceutical and biotech companies must build scientific credibility and investor confidence simultaneously.
Signs pharmaceutical & biotech companies recognise
Does this sound
familiar?
Why this hits pharmaceutical & biotech companies hardest
Sector-specific
pressure points.
Brand not communicating scientific rigour and clinical credibility to investors and KOLs
No digital strategy for building awareness with HCPs before a product launch
Website failing to explain complex mechanism-of-action in terms stakeholders understand
No content strategy building authority in a competitive therapeutic area
Our approach
How we fix it
for pharmaceutical & biotech companies.
Attribution Audit
We assess your current tracking and reporting to find where the connection between marketing activity and revenue breaks down.
Attribution Model & Reporting
We build an attribution model and reporting structure that connects specific marketing activity to actual pipeline and revenue.
Executive-Ready Reporting
We build reporting in the language leadership actually cares about - revenue impact, not clicks and impressions.
Ongoing ROI Tracking
We keep the reporting current so ROI conversations become a routine data review, not a scramble each quarter.
What pharmaceutical & biotech companies gain
Real outcomes.
A clear, defensible connection between marketing spend and revenue
Reporting built around business outcomes leadership actually cares about
A stronger position to defend or grow marketing budget with data
FAQ
Common questions.
Do you specifically fix can't prove marketing roi for pharmaceutical & biotech companies?
Yes. We understand the specific commercial context pharmaceutical & biotech companies operate in, and we apply that context directly to how we fix can't prove marketing roi.
What causes can't prove marketing roi for a pharmaceutical & biotech?
No proper attribution model connecting marketing touchpoints to closed revenue These issues tend to compound for pharmaceutical & biotech companies because of brand not communicating scientific rigour and clinical credibility to investors and kols.
How quickly can you fix can't prove marketing roi for our pharmaceutical & biotech?
Most engagements addressing can't prove marketing roi for pharmaceutical & biotech companies show measurable movement within 30–60 days, with the full fix delivered over 4–10 weeks depending on scope.
What results should a pharmaceutical & biotech expect?
A clear, defensible connection between marketing spend and revenue Reporting built around business outcomes leadership actually cares about
Do you work with pharmaceutical & biotech companies outside our home market?
Yes - we work with pharmaceutical & biotech companies across North America, the UK, UAE, Europe, and Asia Pacific, delivered fully remotely.
Explore more
Related pages.
Other Problems We Solve for Pharmaceutical & Biotech Companies
- Poor Lead Quality for Pharmaceutical & Biotech Companies
- Low Social Media Engagement for Pharmaceutical & Biotech Companies
- Poor Email Open and Click Rates for Pharmaceutical & Biotech Companies
- Competitors Outranking Us in Paid Ads for Pharmaceutical & Biotech Companies
- Social Media Gets Likes But No Sales for Pharmaceutical & Biotech Companies
Can't Prove Marketing ROI for Pharmaceutical & Biotech Companies
Ready to fix
this for your pharmaceutical & biotech?
Book a discovery call. No pitch, no pressure - just a focused conversation about where you are and where you want to be.